# Phase I Perifosine and Gemcitabine Study

> **NCT00398697** · PHASE1 · COMPLETED · sponsor: **AEterna Zentaris** · enrollment: 19 (—)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Perifosine
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00398697
- **Lead sponsor:** AEterna Zentaris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 19 (—)
- **Last updated:** 2014-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398697, "Phase I Perifosine and Gemcitabine Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00398697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*